[
    [
        {
            "time": "2018-03-27",
            "original_text": "明日最具投资机会六大牛股一览（2018年3月27日）",
            "features": {
                "keywords": [
                    "投资机会",
                    "牛股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "明日最具投资机会六大牛股一览（2018年3月27日）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "中财独家:百股涨停再现 A股市场仍有可为？机构预测",
            "features": {
                "keywords": [
                    "涨停",
                    "A股",
                    "机构预测"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中财独家:百股涨停再现 A股市场仍有可为？机构预测",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "[推荐评级]医药行业周报：三把“火”有望催化医药“大年”",
            "features": {
                "keywords": [
                    "推荐评级",
                    "医药行业",
                    "周报",
                    "催化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：三把“火”有望催化医药“大年”",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "[审慎增持评级]益丰药房(603939)年报点评：业绩稳健增长 持续外延布局",
            "features": {
                "keywords": [
                    "审慎增持",
                    "益丰药房",
                    "年报",
                    "业绩增长"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[审慎增持评级]益丰药房(603939)年报点评：业绩稳健增长 持续外延布局",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "[买入评级]益丰药房(603939)年报点评：快速扩张规模+盈利能力提升 业绩高速增长",
            "features": {
                "keywords": [
                    "买入评级",
                    "益丰药房",
                    "年报",
                    "扩张",
                    "盈利能力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]益丰药房(603939)年报点评：快速扩张规模+盈利能力提升 业绩高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "国家卫生健康委员会正式挂牌 医药创新时代首选重配医药",
            "features": {
                "keywords": [
                    "国家卫生健康委员会",
                    "医药创新",
                    "重配医药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国家卫生健康委员会正式挂牌 医药创新时代首选重配医药",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "[领先大市-B评级]医药行业周度报告：深化改革再发文 推行高值耗材“两票制”",
            "features": {
                "keywords": [
                    "领先大市",
                    "医药行业",
                    "深化改革",
                    "两票制"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[领先大市-B评级]医药行业周度报告：深化改革再发文 推行高值耗材“两票制”",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "益丰药房2017年营收48亿 深耕中南华东市场",
            "features": {
                "keywords": [
                    "益丰药房",
                    "营收",
                    "中南华东市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房2017年营收48亿 深耕中南华东市场",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-27",
            "original_text": "【医药丨周小刚】益丰药房(603939)：扣非利润实现42%增长，精细化运营龙头优势凸显",
            "features": {
                "keywords": [
                    "扣非利润",
                    "增长",
                    "精细化运营",
                    "龙头优势"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药丨周小刚】益丰药房(603939)：扣非利润实现42%增长，精细化运营龙头优势凸显",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]